211 related articles for article (PubMed ID: 7680834)
1. Long-term treatment of Laron type dwarfs with insulin-like growth factor-1 increases serum insulin-like growth factor-binding protein-3 in the absence of growth hormone activity.
Kanety H; Karasik A; Klinger B; Silbergeld A; Laron Z
Acta Endocrinol (Copenh); 1993 Feb; 128(2):144-9. PubMed ID: 7680834
[TBL] [Abstract][Full Text] [Related]
2. Effects of exogenous insulin-like growth factor I on insulin-like growth factor binding proteins in a case of growth hormone insensitivity (Laron-type).
Gourmelen M; Perin L; Binoux M
Acta Paediatr Scand Suppl; 1991; 377():115-7. PubMed ID: 1723834
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone insensitivity syndromes: a preliminary report on changes in insulin-like growth factors and their binding proteins during treatment with recombinant insulin-like growth factor I. Kabi Pharmacia Study Group on Insulin-like Growth Factor I Treatment in Growth Hormone Insensitivity Syndromes.
Blum WF; Hall K; Ranke MB; Wilton P
Acta Paediatr Suppl; 1993 Sep; 82 Suppl 391():15-9. PubMed ID: 7693071
[TBL] [Abstract][Full Text] [Related]
4. IGF binding protein 3 in patients with Laron type dwarfism: effect of exogenous rIGF-I.
Laron Z; Klinger B; Blum WF; Silbergeld A; Ranke MB
Clin Endocrinol (Oxf); 1992 Mar; 36(3):301-4. PubMed ID: 1373347
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone and insulin-like growth factor regulate insulin-like growth factor-binding protein-1 in Laron type dwarfism, growth hormone deficiency and constitutional short stature.
Laron Z; Suikkari AM; Klinger B; Silbergeld A; Pertzelan A; Seppälä M; Koivisto VA
Acta Endocrinol (Copenh); 1992 Oct; 127(4):351-8. PubMed ID: 1280392
[TBL] [Abstract][Full Text] [Related]
6. IGFs and IGF-binding proteins in short children with steroid-dependent nephrotic syndrome on chronic glucocorticoids: changes with 1 year exogenous GH.
Zhou X; Loke KY; Pillai CC; How HK; Yap HK; Lee KO
Eur J Endocrinol; 2001 Mar; 144(3):237-43. PubMed ID: 11248742
[TBL] [Abstract][Full Text] [Related]
7. The insulin-like growth factor (IGF)-binding proteins and IGF bioactivity in Laron-type dwarfism.
Cotterill AM; Holly JM; Taylor AM; Davies SC; Coulson VJ; Preece MA; Wass JA; Savage MO
J Clin Endocrinol Metab; 1992 Jan; 74(1):56-63. PubMed ID: 1370165
[TBL] [Abstract][Full Text] [Related]
8. Expression of serum insulin-like growth factors, insulin-like growth factor-binding proteins, and the growth hormone-binding protein in heterozygote relatives of Ecuadorian growth hormone receptor deficient patients.
Fielder PJ; Guevara-Aguirre J; Rosenbloom AL; Carlsson L; Hintz RL; Rosenfeld RG
J Clin Endocrinol Metab; 1992 Apr; 74(4):743-50. PubMed ID: 1372321
[TBL] [Abstract][Full Text] [Related]
9. The effect of recombinant human insulin-like growth factor-I treatment on growth hormone secretion in two subjects with growth hormone insensitivity (Laron syndrome).
Cotterill AM; Camacho-Hübner C; Holly JM; Savage MO
Clin Endocrinol (Oxf); 1993 Jul; 39(1):119-22. PubMed ID: 7688671
[TBL] [Abstract][Full Text] [Related]
10. Long-term effects of insulin-like growth factor (IGF)-I on serum IGF-I, IGF-binding protein-3 and acid labile subunit in Laron syndrome patients with normal growth hormone binding protein.
Kanety H; Silbergeld A; Klinger B; Karasik A; Baxter RC; Laron Z
Eur J Endocrinol; 1997 Dec; 137(6):626-30. PubMed ID: 9437227
[TBL] [Abstract][Full Text] [Related]
11. The composition and distribution of insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBPs) in the serum of growth hormone receptor-deficient patients: effects of IGF-I therapy on IGFBP-3.
Gargosky SE; Wilson KF; Fielder PJ; Vaccarello MA; Guevara-Aguirre J; Diamond FB; Baxter RC; Rosenbloom AL; Rosenfeld RG
J Clin Endocrinol Metab; 1993 Dec; 77(6):1683-9. PubMed ID: 7505289
[TBL] [Abstract][Full Text] [Related]
12. Regulation of serum insulin-like growth factors and their binding proteins in Ecuadorean patients with growth hormone receptor dysfunction (growth hormone insensitivity).
Fielder PJ; Guevara-Aguirre J; Rosenbloom AL; Cohen P; Hintz RL; Rosenfeld RG
Acta Paediatr Scand Suppl; 1991; 377():104-9. PubMed ID: 1723833
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factors-I and -II and their binding proteins during postnatal development of dwarf Snell mice before and during growth hormone and thyroxine therapy.
van Buul-Offers SC; Bloemen RJ; Reijnen-Gresnigt MG; van Leiden HA; Hoogerbrugge CM; Van den Brande JL
J Endocrinol; 1994 Oct; 143(1):191-8. PubMed ID: 7525829
[TBL] [Abstract][Full Text] [Related]
14. Administration of growth hormone (GH), but not insulin-like growth factor-I (IGF-I), by continuous infusion can induce the formation of the 150-kilodalton IGF-binding protein-3 complex in GH-deficient rats.
Gargosky SE; Tapanainen P; Rosenfeld RG
Endocrinology; 1994 May; 134(5):2267-76. PubMed ID: 7512499
[TBL] [Abstract][Full Text] [Related]
15. Use of insulin-like growth factor-binding protein-2 (IGFBP-2), IGFBP-3, and IGF-I for assessing growth hormone status in short children.
Smith WJ; Nam TJ; Underwood LE; Busby WH; Celnicker A; Clemmons DR
J Clin Endocrinol Metab; 1993 Nov; 77(5):1294-9. PubMed ID: 7521346
[TBL] [Abstract][Full Text] [Related]
16. Fasting affects serum insulin-like growth factors (IGFs) and IGF-binding proteins differently in patients with noninsulin-dependent diabetes mellitus versus healthy nonobese and obese subjects.
Bang P; Brismar K; Rosenfeld RG; Hall K
J Clin Endocrinol Metab; 1994 Apr; 78(4):960-7. PubMed ID: 7512573
[TBL] [Abstract][Full Text] [Related]
17. Differential regulation of insulin-like growth factor-(IGF) I and IGF-binding protein (IGFBP) secretion by human peripheral blood mononuclear cells.
Auernhammer CJ; Fottner C; Engelhardt D; Bidlingmaier M; Strasburger CJ; Weber MM
Horm Res; 2002; 57(1-2):15-21. PubMed ID: 12006714
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone deficiency in 'little' mice results in aberrant body composition, reduced insulin-like growth factor-I and insulin-like growth factor-binding protein-3 (IGFBP-3), but does not affect IGFBP-2, -1 or -4.
Donahue LR; Beamer WG
J Endocrinol; 1993 Jan; 136(1):91-104. PubMed ID: 7679139
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of thyroid hormone action on the insulin-like growth factor system: all thyroid hormone effects are not growth hormone mediated.
Näntö-Salonen K; Muller HL; Hoffman AR; Vu TH; Rosenfeld RG
Endocrinology; 1993 Feb; 132(2):781-8. PubMed ID: 7678799
[TBL] [Abstract][Full Text] [Related]
20. Complex pattern of insulin-like growth factor binding protein expression in primary rat osteoblast enriched cultures: regulation by prostaglandin E2, growth hormone, and the insulin-like growth factors.
McCarthy TL; Casinghino S; Centrella M; Canalis E
J Cell Physiol; 1994 Jul; 160(1):163-75. PubMed ID: 7517403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
